215 related articles for article (PubMed ID: 22983899)
1. Gastrin receptor pharmacology.
Dockray GJ; Moore A; Varro A; Pritchard DM
Curr Gastroenterol Rep; 2012 Dec; 14(6):453-9. PubMed ID: 22983899
[TBL] [Abstract][Full Text] [Related]
2. Inactivating cholecystokinin-2 receptor inhibits progastrin-dependent colonic crypt fission, proliferation, and colorectal cancer in mice.
Jin G; Ramanathan V; Quante M; Baik GH; Yang X; Wang SS; Tu S; Gordon SA; Pritchard DM; Varro A; Shulkes A; Wang TC
J Clin Invest; 2009 Sep; 119(9):2691-701. PubMed ID: 19652364
[TBL] [Abstract][Full Text] [Related]
3. Valine-286 residue in the third intracellular loop of the cholecystokinin 2 receptor exerts a pivotal role in cholecystokinin 2 receptor mediated intracellular signal transduction in human colon cancer cells.
Yu HG; Schäfer H; Mergler S; Müerköster S; Cramer T; Höcker M; Herzig KH; Schmidt WE; Schmitz F
Cell Signal; 2005 Dec; 17(12):1505-15. PubMed ID: 15951156
[TBL] [Abstract][Full Text] [Related]
4. Progress in developing cholecystokinin (CCK)/gastrin receptor ligands that have therapeutic potential.
Berna MJ; Tapia JA; Sancho V; Jensen RT
Curr Opin Pharmacol; 2007 Dec; 7(6):583-92. PubMed ID: 17997137
[TBL] [Abstract][Full Text] [Related]
5. Potential clinical indications for a CCK
Boyce M; Lloyd KA; Pritchard DM
Curr Opin Pharmacol; 2016 Dec; 31():68-75. PubMed ID: 27710813
[TBL] [Abstract][Full Text] [Related]
6. Promoting role of cholecystokinin 2 receptor (CCK2R) in gastrointestinal stromal tumour pathogenesis.
Quattrone A; Dewaele B; Wozniak A; Bauters M; Vanspauwen V; Floris G; Schöffski P; Chibon F; Coindre JM; Sciot R; Debiec-Rychter M
J Pathol; 2012 Dec; 228(4):565-74. PubMed ID: 22786615
[TBL] [Abstract][Full Text] [Related]
7. Progastrin stimulates colonic cell proliferation via CCK2R- and β-arrestin-dependent suppression of BMP2.
Jin G; Westphalen CB; Hayakawa Y; Worthley DL; Asfaha S; Yang X; Chen X; Si Y; Wang H; Tailor Y; Friedman RA; Wang TC
Gastroenterology; 2013 Oct; 145(4):820-30.e10. PubMed ID: 23891976
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle dependent expression of the CCK2 receptor by gastrointestinal myofibroblasts: putative role in determining cell migration.
Varga A; Kumar JD; Simpson AWM; Dodd S; Hegyi P; Dockray GJ; Varro A
Physiol Rep; 2017 Oct; 5(19):. PubMed ID: 29038353
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a novel five-transmembrane domain cholecystokinin-2 receptor splice variant identified in human tumors.
Sanchez C; Escrieut C; Clerc P; Gigoux V; Waser B; Reubi JC; Fourmy D
Mol Cell Endocrinol; 2012 Feb; 349(2):170-9. PubMed ID: 22040601
[TBL] [Abstract][Full Text] [Related]
10. Regulation of membrane cholecystokinin-2 receptor by agonists enables classification of partial agonists as biased agonists.
Magnan R; Masri B; Escrieut C; Foucaud M; Cordelier P; Fourmy D
J Biol Chem; 2011 Feb; 286(8):6707-19. PubMed ID: 21156802
[TBL] [Abstract][Full Text] [Related]
11. Role of progastrins and gastrins and their receptors in GI and pancreatic cancers: targets for treatment.
Rengifo-Cam W; Singh P
Curr Pharm Des; 2004; 10(19):2345-58. PubMed ID: 15279613
[TBL] [Abstract][Full Text] [Related]
12. Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors.
Lloyd KA; Parsons BN; Burkitt MD; Moore AR; Papoutsopoulou S; Boyce M; Duckworth CA; Exarchou K; Howes N; Rainbow L; Fang Y; Oxvig C; Dodd S; Varro A; Hall N; Pritchard DM
Cell Mol Gastroenterol Hepatol; 2020; 10(1):113-132. PubMed ID: 32004755
[TBL] [Abstract][Full Text] [Related]
13. Gastrin stimulates a cholecystokinin-2-receptor-expressing cardia progenitor cell and promotes progression of Barrett's-like esophagus.
Lee Y; Urbanska AM; Hayakawa Y; Wang H; Au AS; Luna AM; Chang W; Jin G; Bhagat G; Abrams JA; Friedman RA; Varro A; Wang KK; Boyce M; Rustgi AK; Sepulveda AR; Quante M; Wang TC
Oncotarget; 2017 Jan; 8(1):203-214. PubMed ID: 27448962
[TBL] [Abstract][Full Text] [Related]
14. Regulation of mammalian gastrin/CCK receptor (CCK2R) expression in vitro and in vivo.
Ashurst HL; Varro A; Dimaline R
Exp Physiol; 2008 Feb; 93(2):223-36. PubMed ID: 17933865
[TBL] [Abstract][Full Text] [Related]
15. Gastrin acting on the cholecystokinin2 receptor induces cyclooxygenase-2 expression through JAK2/STAT3/PI3K/Akt pathway in human gastric cancer cells.
Xu W; Chen GS; Shao Y; Li XL; Xu HC; Zhang H; Zhu GQ; Zhou YC; He XP; Sun WH
Cancer Lett; 2013 May; 332(1):11-8. PubMed ID: 23376640
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the effects of gastrin, somatostatin and dopamine receptor ligands on rat gastric enterochromaffin-like cell secretion and proliferation.
Kidd M; Modlin IM; Black JW; Boyce M; Culler M
Regul Pept; 2007 Oct; 143(1-3):109-17. PubMed ID: 17531331
[TBL] [Abstract][Full Text] [Related]
17. Targeting gastrin for the treatment of gastric acid related disorders and pancreatic cancer.
Morton M; Prendergast C; Barrett TD
Trends Pharmacol Sci; 2011 Apr; 32(4):201-5. PubMed ID: 21397342
[TBL] [Abstract][Full Text] [Related]
18. SRC regulates constitutive internalization and rapid resensitization of a cholecystokinin 2 receptor splice variant.
Chao C; Ives KL; Goluszko E; Kolokoltsov AA; Davey RA; Townsend CM; Hellmich MR
J Biol Chem; 2005 Sep; 280(39):33368-73. PubMed ID: 16079138
[TBL] [Abstract][Full Text] [Related]
19. [A study of gastrin-focal adhesion kinase signal pathway in human colon cancer cells].
Ding J; Yu JP; Li D; Luo HS; Yu HG
Zhonghua Nei Ke Za Zhi; 2005 Jun; 44(6):434-7. PubMed ID: 16008856
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a nonpeptidic ligand for imaging of cholecystokinin 2 receptor-expressing cancers.
Wayua C; Low PS
J Nucl Med; 2015 Jan; 56(1):113-9. PubMed ID: 25500824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
